Kiliki ii pe afai o lau faʻasalalauga lea!

Novavax Heads i le World Vaccine Congress Europe

tusia e faʻatonu

O le kamupani o le Biotechnology Novavax, Inc. o loʻo faʻapitoa mo le atinaʻeina ma le faʻapisinisi o tui puipuia mo isi faʻamaʻi pipisi, na faʻalauiloa mai nei e le Vivek Shinde, MD, Sui Peresetene, Clinical Development, o le a faia sana folasaga i le taimi o le World Vaccine Congress Europe 2021.

Print Friendly, PDF & Email

O le autu o le talanoaga o le Novavax 'COVID-NanoFlu ™ Combination Vaccine, lea e tuʻufaʻatasia ai le kamupani recubinant nanoparticle protein-faʻavae COVID-19 ma NanoFlu ™ tui sui tauva ma Matrix-M ™ adjuvant i se tasi faʻavae.       

O auiliiliga o sauniga e faapenei:

Aso: Aso Lulu, Oketopa 20, 2021
Taimi: 11:30 am - 12:00 pm Tutotonu Europa Taimi (CET) /
 
5:30 i le taeao - 6:00 i le taeao sasaʻe o le ao (EDT)
Igoa: Faʻafouga i le Novavax 'NanoFlu vaccine ma COVID-19-NanoFlu Combination Vaccine development
Novavax Tagata auai: Vivek Shinde, MD, Sui Peresetene, Atinaʻe Faʻafomaʻi
 
 

Ua tuʻufaʻatasia le malosiʻaga ma le saoasaoa o le gafa faʻatekinolosi o le kamupani e faʻatupeina ai le sili atu o le nanano oona puipuia oona faʻatulagaina e faʻatonutonu ai manaʻoga faʻafuaseʻi o le soifua maloloina. O Novavax o loʻo ia faia faʻataʻitaʻiga o falemaʻi mo le NVX-CoV2373, o lona sui tauva faʻasaga i le SARS-CoV-2, o le siama e mafua ai le COVID-19. O le NanoFlu ™, o lona vailaʻau faʻapitoa lea na mafua ai le taua i le vaega taua o le Phase 3 i le au matutua. O sui tauva uma e lua o loʻo tuʻufaʻatasia Novavax 'proprietary saponin-based Matrix-M ™ adjuvant e faʻaleleia ai le tali atu o le puipuiga ma faʻamalosia le maualuga o le tuʻufaʻatasia o vailaʻau.

Print Friendly, PDF & Email

E uiga i le tusitala

faʻatonu

O le faatonu sili o Linda Hohnholz.

Tuua se Faamatalaga